Alex Fardman retweeted
A State-of-the-Art Review published in #JACC provides a comprehensive overview of support and management of dLVAD-related emergencies, with an intent to provide a rapid-response guide for clinicians who encounter emergencies in patients with dLVADs. 🔗 bit.ly/4sOg4G6
Alex Fardman retweeted
Distinct residual #congestion phenotypes carry different risks,
From #PROTECT & #RELAX_AHF_2:
📍37% of #ADHF patients remain #congested at discharge
📍Intravascular residual congestion: best diuretic response, but still ⬆️mortality☠️ compared to decongested patients
📍Tissue/combined residual congestion: poor diuretic response & highest risk⚠️
📍Residual congestion assessment helps identify high-risk patients, & future studies should evaluate phenotype-guided strategies
Read more #EJHF: doi.org/10.1002/ejhf.70091
@escardio @EJHFEiC @MarcoMetra @jozinetm @DukeHFDoc @AdriaanVoors @HFSA @EJHFEiC @Filippatos @GianluSava @WilfriedMullens
#Decongestion #DiuresisJedi #GDMTworks #CardioX #CardioTwitter
Alex Fardman retweeted
Unlike intact HM3 bend reliefs that permit biodebris accumulation, perforated HM3 bend-reliefs enable exfiltration of biodebris & infiltration of cells and collagen to mitigate potential graft obstruction risk. @soultanofswing
🔗: jhltonline.org/article/S1053…
Alex Fardman retweeted
Care involving a #heartfailure specialist during an admission for HF ➡️ increased rates of #GDMT, decreased diuretics, lower in-hospital and long-term mortality, especially in #HFrEF, although across all #LVEF. jacc.org/doi/10.1016/j.jchf.…
#JACCHF #GDMTworks @_antocannata
Alex Fardman retweeted
Calling all U.S. cardiologists and cardiology fellows! Dr. Ross Koppel @PennMedicine and I are studying the documentation burden in cardiology. Please share your insights in our short survey: forms.gle/FN2WqtbfhHCGSNzG6 #Cardiology #HealthIT #Usability #EMR #EHR #Cardiotwitter #FIT
I was thrilled to give a talk, discuss and moderate with an esteemed colleagues at 8th #eacts MCS summit in the beautiful city of Prague.
State of the art lectures and cutting edge developments in the MCS field.
Cudos to organizers for tremendous job! @netuka_ivan @FinnGustafsson
Despite the war, rockets and incessant alarms, we held earlier this week the first #MCS summit at @sheba_medical. Thank you @EvgenijPotapov and all colleagues that joined us at this meeting. Thanks to @jjmt_heartrecov for providing #impella simulator. @AbbottGlobal @fercherno
Alex Fardman retweeted
#HeartTx has evolved in areas such as patient selection, care of selected patient populations, & utilization of #MCS. This provides a blueprint for a patient centered team approach to selection, care, & MCS while awaiting transplant. @YaelPeledPotash
🔗 jhltonline.org/article/S1053…
Alex Fardman retweeted
Our new findings from the largest national preventive healthcare screening program and cancer registry reveal that ASCVD is linked to a higher risk of metastasis at cancer diagnosis, especially in middle-aged adults.
Read: bit.ly/3N7OYXr
@JACCJournals @CallerTal
Alex Fardman retweeted
📢 A NEW #ISHLT Guideline Document for the evaluation and care of #HeartTransplant candidates is now available. 📖🫀 This document provides recommendations based on contemporary scientific evidence & patient management flow diagrams. Check out the top ten takeaways ⏬ and read the publication at 🔗 bit.ly/4fAuLqm
Alex Fardman retweeted
📌 After diagnosis of #HFrEF, continuous optimiz. of GDMT beyond day 90 till day 180
👉 assoc. w/ additional LVEF ⬆️ >35% in 46% of 👫
‼️ therefore, evaluation of #ICD implantation should not be done before day 180 after diagnosis of HFrEF‼️
#HeartFailure @drjohnm @SeguraCardio
Alex Fardman retweeted
2024 Heart Failure update has just been published in ESC Heart Failure. It's a long read, but worth the time :)
doi.org/10.1002/ehf2.14857
@FudimMarat @MarcoMetra @escardio @Cardiotweet @M_Sokolski @AlexMebazaa @EJHFEiC
Alex Fardman retweeted
Phenomenal talk by @WilfriedMullens about Kidney dysfunction as a cause of diuretic resistance
#HeartFailure2024 #HFA_ESC @escardio @MarcoMetra @mewton_nathan @FH_Verbrugge @markcpetrie20 @pabeda1
Alex Fardman retweeted
Pragmatic real-life RCTs with easy implementable cheap options to treat #heartfailure better by #HFAYoung is one fantastic way to move research forward. Kuddos to @EvelyneMeekers
Replying to @HanCardiomd
EASY-HF
📍Improved natriuresis & diuresis without increased adverse events in ADHF patients.
📍Bedside UNa sensor facilitates rapid diuretic adjustments by nurses, preferred over 24h UC.
📍Standardized protocol + UNa sensor allows personalized diuretic titration in first 48h.
#HeartFailure2024
#ADHF #Diuretics #NursingHF
Alex Fardman retweeted
Do you want #HFA to improve 1) Education, 2) Certification/QCC, 3) Diversity, 4) Scientific Excellence, 5) Advocacy, and 6) Nation Societ in spirit of openness, transparency, interdisciplinary support and mutual respect ?
➡️ ecourage to vote escardio.org/Sub-specialty-c…
➡️ my potential strengths to help HFA
Alex Fardman retweeted
Next step towards personalized diuretic therapy???
➡️ results of the #EASYHF (Nurse-Led Diuretic Titration via Point of Care Urinary Sodium Sensor) to be presented #HeartFailure2024
➡️ Late Breaking Clinical Trial Session May 11 - Room 1 - 1.45-2.45 pm by E.Meekers part of #HFAYoung
@FH_Verbrugge @JeroenDauw @PieterMartensMD @GruwezHenri @petra_nijst @kameloot3 @S_Dhont
Alex Fardman retweeted
Analysis shows that initial declines in HF-related mortality from 1999 to 2012 have been entirely undone by subsequent reversals from 2012 to 2021, meaning that contemporary HF mortality rates are higher than in 1999. ja.ma/3UcwM23
Alex Fardman retweeted
Honored, humbled and very excited to be selected as candidate for position of president-elect for the #HFA board elections!
To all members, please don’t forget to vote for these fantastic people!
escardio.org/Sub-specialty-c…
Here are my top six priorities....together we can make it happen!
#DOACs in #LVAD patients? Hot from #ISHLT2024. Amazing data presented by @netuka_ivan. More studies are warranted. @MRMehraMD @ISHLT
















































